Cargando…
Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital
Bloodstream infection caused by Acinetobacter baumannii has become a major clinical concern, especially multidrug-resistant A baumannii (MDRAB). The aim of this study was to identify the risk factors of nosocomial acquired MDRAB bacteremia and to determine the risk factors related to the mortality o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456023/ https://www.ncbi.nlm.nih.gov/pubmed/30921191 http://dx.doi.org/10.1097/MD.0000000000014937 |
_version_ | 1783409697103020032 |
---|---|
author | Zhou, Hua Yao, Yake Zhu, Bingquan Ren, Danhong Yang, Qing Fu, Yiqi Yu, Yunsong Zhou, Jianying |
author_facet | Zhou, Hua Yao, Yake Zhu, Bingquan Ren, Danhong Yang, Qing Fu, Yiqi Yu, Yunsong Zhou, Jianying |
author_sort | Zhou, Hua |
collection | PubMed |
description | Bloodstream infection caused by Acinetobacter baumannii has become a major clinical concern, especially multidrug-resistant A baumannii (MDRAB). The aim of this study was to identify the risk factors of nosocomial acquired MDRAB bacteremia and to determine the risk factors related to the mortality of patients with MDRAB bacteremia. Patients with nosocomial acquired A baumannii bacteremia were enrolled between January, 2013 and December, 2017 at the First Affiliated Hospital, School of Medicine, Zhejiang University. Medical records were reviewed, and the clinical and microbial characteristics were collected. Among the 338 patients suffering from A baumannii bacteremia, 274 patients were infected with MDRAB bacteremia. Bacteremia-related mortality was 46.4% for the overall sample; 56.2% for MDRAB bacteremia patients, 4.7% for non-MDRAB bacteremia patients. The identified risk factors for developing MDRAB bacteremia were previous exposure to carbapenems [odds ratio (OR) 5.78, P = .005] and penicillins+β-lactamase inhibitors (OR 4.29, P = .009). Primary bacteremia tended to develop non-MDR bacteremia (OR 0.10, P = .002). The risk factors for MDRAB bacteremia-related mortality were old age (OR 1.02, P = .036), a high Pitt bacteremia score (OR 1.32, P < .001), bacteremia occurring after severe pneumonia (OR 8.66, P < .001), while catheter-related infection (OR 0.47, P = .049) and operations for treating infection (OR 0.51, P = .043) may have a better outcome. Patients with MDRAB had a higher mortality rate. Patients with previous carbapenems and penicillins+β-lactamase inhibitor exposure are at an increased risk of MDRAB bacteremia, whereas patients with primary bacteremia tended to develop non-MDR bacteremia. The risk factors for MDRAB bacteremia-related mortality were old age, a high Pitt bacteremia score, and bacteremia occurring after severe pneumonia, whereas catheter-related infection and operations for the treatment of infection may have a better outcome. |
format | Online Article Text |
id | pubmed-6456023 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-64560232019-05-29 Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital Zhou, Hua Yao, Yake Zhu, Bingquan Ren, Danhong Yang, Qing Fu, Yiqi Yu, Yunsong Zhou, Jianying Medicine (Baltimore) Research Article Bloodstream infection caused by Acinetobacter baumannii has become a major clinical concern, especially multidrug-resistant A baumannii (MDRAB). The aim of this study was to identify the risk factors of nosocomial acquired MDRAB bacteremia and to determine the risk factors related to the mortality of patients with MDRAB bacteremia. Patients with nosocomial acquired A baumannii bacteremia were enrolled between January, 2013 and December, 2017 at the First Affiliated Hospital, School of Medicine, Zhejiang University. Medical records were reviewed, and the clinical and microbial characteristics were collected. Among the 338 patients suffering from A baumannii bacteremia, 274 patients were infected with MDRAB bacteremia. Bacteremia-related mortality was 46.4% for the overall sample; 56.2% for MDRAB bacteremia patients, 4.7% for non-MDRAB bacteremia patients. The identified risk factors for developing MDRAB bacteremia were previous exposure to carbapenems [odds ratio (OR) 5.78, P = .005] and penicillins+β-lactamase inhibitors (OR 4.29, P = .009). Primary bacteremia tended to develop non-MDR bacteremia (OR 0.10, P = .002). The risk factors for MDRAB bacteremia-related mortality were old age (OR 1.02, P = .036), a high Pitt bacteremia score (OR 1.32, P < .001), bacteremia occurring after severe pneumonia (OR 8.66, P < .001), while catheter-related infection (OR 0.47, P = .049) and operations for treating infection (OR 0.51, P = .043) may have a better outcome. Patients with MDRAB had a higher mortality rate. Patients with previous carbapenems and penicillins+β-lactamase inhibitor exposure are at an increased risk of MDRAB bacteremia, whereas patients with primary bacteremia tended to develop non-MDR bacteremia. The risk factors for MDRAB bacteremia-related mortality were old age, a high Pitt bacteremia score, and bacteremia occurring after severe pneumonia, whereas catheter-related infection and operations for the treatment of infection may have a better outcome. Wolters Kluwer Health 2019-03-15 /pmc/articles/PMC6456023/ /pubmed/30921191 http://dx.doi.org/10.1097/MD.0000000000014937 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | Research Article Zhou, Hua Yao, Yake Zhu, Bingquan Ren, Danhong Yang, Qing Fu, Yiqi Yu, Yunsong Zhou, Jianying Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital |
title | Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital |
title_full | Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital |
title_fullStr | Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital |
title_full_unstemmed | Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital |
title_short | Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital |
title_sort | risk factors for acquisition and mortality of multidrug-resistant acinetobacter baumannii bacteremia: a retrospective study from a chinese hospital |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456023/ https://www.ncbi.nlm.nih.gov/pubmed/30921191 http://dx.doi.org/10.1097/MD.0000000000014937 |
work_keys_str_mv | AT zhouhua riskfactorsforacquisitionandmortalityofmultidrugresistantacinetobacterbaumanniibacteremiaaretrospectivestudyfromachinesehospital AT yaoyake riskfactorsforacquisitionandmortalityofmultidrugresistantacinetobacterbaumanniibacteremiaaretrospectivestudyfromachinesehospital AT zhubingquan riskfactorsforacquisitionandmortalityofmultidrugresistantacinetobacterbaumanniibacteremiaaretrospectivestudyfromachinesehospital AT rendanhong riskfactorsforacquisitionandmortalityofmultidrugresistantacinetobacterbaumanniibacteremiaaretrospectivestudyfromachinesehospital AT yangqing riskfactorsforacquisitionandmortalityofmultidrugresistantacinetobacterbaumanniibacteremiaaretrospectivestudyfromachinesehospital AT fuyiqi riskfactorsforacquisitionandmortalityofmultidrugresistantacinetobacterbaumanniibacteremiaaretrospectivestudyfromachinesehospital AT yuyunsong riskfactorsforacquisitionandmortalityofmultidrugresistantacinetobacterbaumanniibacteremiaaretrospectivestudyfromachinesehospital AT zhoujianying riskfactorsforacquisitionandmortalityofmultidrugresistantacinetobacterbaumanniibacteremiaaretrospectivestudyfromachinesehospital |